Monocyte activation for enhanced tumour necrosis factor-α and interleukin 6 production during chronic renal allograft rejection
- 31 March 1994
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 2 (1) , 35-40
- https://doi.org/10.1016/0966-3274(94)90075-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- TUMOR NECROSIS FACTOR ALPHA IN HUMAN KIDNEY TRANSPLANT REJECTION—ANALYSIS BY IN SITU HYBRIDIZATIONTransplantation, 1993
- CHRONIC VASCULAR REJECTION OF THE HEART AND THE KIDNEY—HAVE RATIONAL TREATMENT OPTIONS EMERGED?Transplantation, 1992
- IMMUNOPATHOLOGICAL PATTERNS IN LONG-TERM RENAL ALLOGRAFTSTransplantation, 1991
- CHRONIC REJECTION IN PRIMARY RENAL ALLOGRAFT RECIPIENTS UNDER CYCLOSPORINE-PREDNISONE IMMUNOSUPPRESSIVE THERAPYTransplantation, 1991
- Glucocorticoids inhibit the production of IL 6 from monocytes, endothelial cells and fibroblastsEuropean Journal of Immunology, 1990
- CAUSES OF GRAFT LOSS BEYOND TWO YEARS IN THE CYCLOSPORINE ERATransplantation, 1990
- Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor αKidney International, 1990
- Blood–membrane interaction in hemodialysis leads to increased cytokine productionKidney International, 1987
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976